e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical and laboratory pharmacology in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Icaritin inhibited ovalbumin-induced airway inflammation in murine model
D. Yao (Guilin, China), B. Xiao (Guilin, China), G. Zhou (Guilin, China), B. Mo (Guilin, China)
Source:
Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Session:
Clinical and laboratory pharmacology in asthma
Session type:
E-poster session
Number:
1406
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Yao (Guilin, China), B. Xiao (Guilin, China), G. Zhou (Guilin, China), B. Mo (Guilin, China). Icaritin inhibited ovalbumin-induced airway inflammation in murine model. 1406
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Narirutin inhibits airway inflammation in an allergic mouse model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001
The PAR
2
-activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004
AQP5 role in ovalbumin-induced airway inflammation and secretion of MUC5AC in mice
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008
HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Effect of 1,25(OH)
2
D
3
on the airway inflammation in asthmatic rat model
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005
Absence of proton-sensing TDAG8 protects against ovalbumin-induced allergic airway inflammation
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats
Source: Eur Respir J 2006; 27: 726-734
Year: 2006
PDE-4-inhibitor rolipram supports treg-mediated suppression in a murine model of allergic airway disease
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Development of IL-33-induced asthmatic airway inflammation in human IL-3/GM-CSF/IL-5-transgenic NOG mice
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice
Source: Eur Respir J 2009; 34: 200-208
Year: 2009
Effect of choline chloride in allergen-induced mouse model of airway inflammation
Source: Eur Respir J 2007; 30: 662-671
Year: 2007
Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 690s
Year: 2004
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept